145 related articles for article (PubMed ID: 28906023)
1. Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.
Lehman JS; Hashmi SK; Lazarus HM; El-Azhary RA; Gibson LE; Hogan WJ; Litzow MR; Patnaik MS; Buadi F; Lacy MQ; Dasari S; Vanderboom P; Meves A
J Cutan Pathol; 2017 Dec; 44(12):1087-1091. PubMed ID: 28906023
[No Abstract] [Full Text] [Related]
2. Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
Divito SJ; Aasebø AT; Matos TR; Hsieh PC; Collin M; Elco CP; O'Malley JT; Bækkevold ES; Reims H; Gedde-Dahl T; Hagerstrom M; Hilaire J; Lian JW; Milford EL; Pinkus GS; Ho VT; Soiffer RJ; Kim HT; Mihm MC; Ritz J; Guleria I; Cutler CS; Clark RA; Jahnsen FL; Kupper TS
J Clin Invest; 2020 Sep; 130(9):4624-4636. PubMed ID: 32516138
[TBL] [Abstract][Full Text] [Related]
3. Pathology findings in patients with cutaneous T-cell lymphomas treated with allogeneic haematopoietic stem cell transplantation.
Menter T; Medani H; Olavarria E; Kanfer E; Naresh KN
Br J Haematol; 2018 Mar; 180(6):904-908. PubMed ID: 27984647
[No Abstract] [Full Text] [Related]
4. Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.
Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
Ann Hematol; 2019 Aug; 98(8):1867-1875. PubMed ID: 30993415
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte-derived amyloidosis as a manifestation of chronic graft-versus-host disease.
Haemel A; Fox L; McCalmont TH
J Cutan Pathol; 2013 Mar; 40(3):291-4. PubMed ID: 23899263
[No Abstract] [Full Text] [Related]
6. Colonic graft-vs.-host disease in autologous versus allogeneic transplant patients: earlier onset, more apoptosis, and lack of regulatory T-cell attenuation.
Hartley CP; Carrillo-Polanco LF; Rowan DJ; Hagen CE
Mod Pathol; 2018 Oct; 31(10):1619-1626. PubMed ID: 29899549
[TBL] [Abstract][Full Text] [Related]
7. Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease.
Malard F; Bossard C; Brissot E; Chevallier P; Guillaume T; Delaunay J; Mosnier JF; Moreau P; Grégoire M; Gaugler B; Mohty M
J Leukoc Biol; 2013 Dec; 94(6):1337-43. PubMed ID: 23990625
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic and immunophenotypic features of cutaneous solid organ transplant-associated graft-vs-host disease: Comparison with acute hematopoietic cell transplant-associated graft-vs-host disease and cutaneous drug eruption.
Russell AJ; Musiek AC; Staser KW; Rosman IS
J Cutan Pathol; 2021 Dec; 48(12):1480-1488. PubMed ID: 34173980
[TBL] [Abstract][Full Text] [Related]
9. Role of Toll-like receptor 4 signaling in cutaneous chronic graft-versus-host disease.
Weng J; Lai P; Geng S; Luo C; Wu S; Ling W; Deng C; Huang X; Lu Z; Du X
Clin Transplant; 2015 Jun; 29(6):547-54. PubMed ID: 25845646
[TBL] [Abstract][Full Text] [Related]
10. Eruption of lymphocyte recovery or autologous graft-versus-host disease?
Nellen RG; van Marion AM; Frank J; Poblete-Gutiérrez P; Steijlen PM
Int J Dermatol; 2008 Nov; 47 Suppl 1():32-4. PubMed ID: 18986483
[TBL] [Abstract][Full Text] [Related]
11. Atopic Dermatitis-like Graft-versus-host Disease and Lichen Planus-like Graft-versus-host Disease: Alterations in Skin Barrier Function and Related Molecules.
Li K; Mu ZL; Chen X; Wen GD; Zhao Y; Zhang JZ
Chin Med J (Engl); 2017 Jun; 130(12):1459-1466. PubMed ID: 28584210
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous graft-versus-host disease].
Karrer S
Hautarzt; 2003 May; 54(5):465-80; quiz 481-2. PubMed ID: 12833893
[TBL] [Abstract][Full Text] [Related]
13. Update on graft versus host disease.
Gilliam AC
J Invest Dermatol; 2004 Aug; 123(2):251-7. PubMed ID: 15245422
[No Abstract] [Full Text] [Related]
14. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.
Cogbill CH; Drobyski WR; Komorowski RA
Mod Pathol; 2011 Jan; 24(1):117-25. PubMed ID: 20953169
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous macrophage infiltration in acute GvHD.
Terakura S; Martin PJ; Shulman HM; Storer BE
Bone Marrow Transplant; 2015 Aug; 50(8):1135-7. PubMed ID: 25961771
[No Abstract] [Full Text] [Related]
16. Immunoselection techniques in hematopoietic stem cell transplantation.
Li Pira G; Biagini S; Cicchetti E; Merli P; Brescia LP; Milano GM; Montanari M
Transfus Apher Sci; 2016 Jun; 54(3):356-63. PubMed ID: 27209628
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease.
Yamakawa T; Ohigashi H; Hashimoto D; Hayase E; Takahashi S; Miyazaki M; Minomi K; Onozawa M; Niitsu Y; Teshima T
Blood; 2018 Mar; 131(13):1476-1485. PubMed ID: 29363541
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
[TBL] [Abstract][Full Text] [Related]
20. Target antigens determine graft-versus-host disease phenotype.
Kaplan DH; Anderson BE; McNiff JM; Jain D; Shlomchik MJ; Shlomchik WD
J Immunol; 2004 Nov; 173(9):5467-75. PubMed ID: 15494494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
